SJS Enterprises
about 3 years ago
IPO Size: Rs. 800 cr – Entirely OFS
- 86% by institutional promoter PE Everstone and balance by individual promoter
Price band: Rs. 531-542 per share
Mcap: Rs. 1,650 cr, implying a massive 48% dilution
IPO Date: Mon 1st Nov to Wed 3rd Nov 2021, Listing 15th Nov 2021:
Grey Market Premium (GMP): We are strongly against ‘grey market premium’ as it is an unofficial figure, against SEBI guidelines.
Company Overview:
Aesthetics ‘design and delivery’ solutions company for Automobile (2W, PV, CV, farm equipment) and Consumer Durables (appliances, medical devices, sanitary ware), with FY21 revenue of Rs. 320 cr, split 70:30 respectively.
Strengths:
- Healthy margins: 29% EBITDA and 16% net margins, leading to FY21 PAT of Rs. 52 cr and EPS of Rs. 17.
- High Cash Generating Business: Debt free balance sheet, with cash surplus of Rs. 70 cr (Rs. 22 per share), even after making a cash acquisition of Exotech for Rs. 64 cr in April 2021.
- Although present industry size is only Rs. 2,000 cr, with highly commoditised and low entry barriers, it is expected to grow at 20% over the next 4 years. SJS enjoys 15% market share.
Concerns:
- Patchy Historic Growth: Q1FY22 topline declined to Rs. 74 cr ver Rs. 320 cr in FY21, which was anyway a covid impacted year. High dependence on 2W in the auto sector (~50% of topline) and its slowdown has impacted past growth. Even in FY20, revenue declined 9% YoY, before jumping 17% in FY21, with capacity utilization stagnant at ~50% for past 3 years.
- Exotech’s 20% EBITDA margins significantly lower than SJS 31%, as former’s material cost is higher. SJS’s margin was impacted by 240 bps in FY21 and further margin pressure was visible in Q1FY21, dropping a further 420 bps to 25%.
- Expensive Valuation: PE multiple of 32x on FY21 basis is hugely aggressive, given small size of operations and patchy topline. Heavy dilution of 48% by promoters is not comforting either.